Open Access. Powered by Scholars. Published by Universities.®

Law Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 13 of 13

Full-Text Articles in Law

Table Of Contents, Annals Of Health Law & Life Sciences Jan 2022

Table Of Contents, Annals Of Health Law & Life Sciences

Annals of Health Law and Life Sciences

No abstract provided.


Welcome To The Digital Age: Reinventing Contact Tracing And The Public Health Service Act For A Modern Pandemic Response, Michael L. Cederblom Jan 2022

Welcome To The Digital Age: Reinventing Contact Tracing And The Public Health Service Act For A Modern Pandemic Response, Michael L. Cederblom

Annals of Health Law and Life Sciences

No abstract provided.


Healthcare Fraud Investigations: Overview Of Overbroad Investigative Regime And Recommendations For A More Targeted Approach, Salvatore Filippello Jan 2022

Healthcare Fraud Investigations: Overview Of Overbroad Investigative Regime And Recommendations For A More Targeted Approach, Salvatore Filippello

Annals of Health Law and Life Sciences

No abstract provided.


Addressing Stigma And False Beliefs About Mental Health: A New Direction For Mental Health Parity Advocacy, Claire Sontheimer, Michael R. Ulrich Jan 2022

Addressing Stigma And False Beliefs About Mental Health: A New Direction For Mental Health Parity Advocacy, Claire Sontheimer, Michael R. Ulrich

Annals of Health Law and Life Sciences

No abstract provided.


Pandemic Response Through Whole Person Care: The Intersection Of Physical And Mental Health And The Law, Jennifer Kinsley Smith, Esq., Elizabeth J. Lattner, Ma, Allison Kreiner, Md, Edward J. Kilbane, Md, Ma, Keyvan Ravakhah, Md, Mba Jan 2022

Pandemic Response Through Whole Person Care: The Intersection Of Physical And Mental Health And The Law, Jennifer Kinsley Smith, Esq., Elizabeth J. Lattner, Ma, Allison Kreiner, Md, Edward J. Kilbane, Md, Ma, Keyvan Ravakhah, Md, Mba

Annals of Health Law and Life Sciences

No abstract provided.


Stumbling Over Trips: The International Intellectual Property Waiver Petition And The U.S. Executive, Jordan Paradise, Christina Conroy Jan 2022

Stumbling Over Trips: The International Intellectual Property Waiver Petition And The U.S. Executive, Jordan Paradise, Christina Conroy

Faculty Publications & Other Works

This article examines the relationship among intellectual property (IP) law protections; United States (U.S.) and international law and policy; and the actualization of diagnostics, drugs, and vaccines in the time of the COVID-19 coronavirus. Two key international treaties that relate to IP law--The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) - establish international norms for the protection of IP. Core aspects of each of these treaties are described along with the role of the World Trade Organization (WTO) and concepts of compulsory licensing. As a result …


Stumbling Over Trips: The International Intellectual Property Waiver Petition And The U.S. Executive, Jordan Paradise, Christina Conroy Jan 2022

Stumbling Over Trips: The International Intellectual Property Waiver Petition And The U.S. Executive, Jordan Paradise, Christina Conroy

Faculty Publications & Other Works

This article examines the relationship among intellectual property (IP) law protections; United States (U.S.) and international law and policy; and the actualization of diagnostics, drugs, and vaccines in the time of the COVID-19 coronavirus. Two key international treaties that relate to IP law--The Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement and the Doha Declaration on the TRIPS Agreement and Public Health (Doha Declaration) - establish international norms for the protection of IP. Core aspects of each of these treaties are described along with the role of the World Trade Organization (WTO) and concepts of compulsory licensing. As a result …


Biosimilar Bias: A Barrier To Addressing American Drug Costs, Cynthia M. Ho Jan 2022

Biosimilar Bias: A Barrier To Addressing American Drug Costs, Cynthia M. Ho

Faculty Publications & Other Works

Forty percent of spiraling US drug costs are based on a mere two percent of all drugs –biologic drugs (biologics) made from living cells that are administered by injection or infusion. These costs will continue to balloon as new biologics are approved; the recently approved Alzheimer’s drug is expected to result in a 50% increase in Medicare spending and cost individuals 40% of their annual income. These drugs are expensive because they cannot be mass-produced, and their cost places important treatments for conditions such as arthritis (Humira) and cancer (Herceptin) out of reach for many Americans. Fortunately, just as there …


Foreword, Meera V. Patel Jan 2022

Foreword, Meera V. Patel

Annals of Health Law and Life Sciences

No abstract provided.


Table Of Contents, Annals Of Health Law And Life Sciences Jan 2022

Table Of Contents, Annals Of Health Law And Life Sciences

Annals of Health Law and Life Sciences

No abstract provided.


Foreword, Meera V. Patel Jan 2022

Foreword, Meera V. Patel

Annals of Health Law and Life Sciences

No abstract provided.


Physician Liability In The Age Of Data Reliance And Errors, Laura Montesantos Jan 2022

Physician Liability In The Age Of Data Reliance And Errors, Laura Montesantos

Annals of Health Law and Life Sciences

No abstract provided.


Mind The App, Leah R. Fowler, Jessica L. Roberts Jan 2022

Mind The App, Leah R. Fowler, Jessica L. Roberts

Annals of Health Law and Life Sciences

No abstract provided.